<DOC>
	<DOCNO>NCT02249299</DOCNO>
	<brief_summary>Adult patient ADHD commonly report improvement behavioural symptom use cannabis reporting preference towards cannabis ADHD stimulant medication . The EMA-C study aim investigate effect cannabis base medication , Sativex Oromucosal Spray behaviour cognition adult ADHD . This carry conduct placebo control trial . 30 adult ADHD take Sativex dummy medication ( placebo ) every day 6 week . There 50 % chance receive Sativex Placebo . Measures behaviour cognition take 6 week treatment . We hypothesise treatment Sativex result improvement behaviour cognition placebo group .</brief_summary>
	<brief_title>Experimental Medicine ADHD - Cannabinoids</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>The study open men woman age 1855 meet DSM 5 criterion ADHD ( N= 30 ) . Subjects either unmedicated medicate stimulant medication willing come medication 1 week duration study . To ensure disadvantage patient include stimulant medication take medication regular basis short period medication think patient psychiatrist represent clinical problem overall control symptoms impairment . For example , include patient consider `` stimulant drug holiday '' , common clinical procedure ADHD . Subjects must use prescription nonprescription medication recreational drug study . Exclusion criterion include autism spectrum disorder psychiatric disorder include recurrent major depression , bipolar I disorder , psychotic disorder obsessive compulsive disorder learn difficulty define IQ &lt; 70 . Neurological problem know suspected history drug alcohol dependence disorder . Subjects use use cannabis cannabis base medication 30 day period prior study entry . Concurrent history renal , hepatic , cardiovascular convulsive disorder . Females pregnant breastfeeding . Female subject child bear potential male subject whose partner child bear potential , unless willing ensure partner use two effective form contraception , example , oral contraception , double barrier , intrauterine device , study three month thereafter ( Note : male condom use conjunction female condom ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>ADHD ,</keyword>
	<keyword>Cannabis ,</keyword>
	<keyword>Sativex ,</keyword>
	<keyword>Endocannabinoid ,</keyword>
	<keyword>Cognition</keyword>
</DOC>